Namuhla kunikezelwe i-multiple sclerosis, isifo esinobuso obuyinkulungwane. Lokhu kungenye isifo sezinzwa esithinta abasebasha kakhulu, nezingane. Ngakho intuthuko ekwelashweni kwabo izokwenza ngcono kakhulu izimpilo zalaba bantu abangathinteka kubo ukulinganiselwa okubalulekile. Lesi yisifo esikhubaza kakhulu.
Ngenxa yophenyo oluningi olwenziwe ekulweni neCovid-19, bakwenzile lokho phambili ekutadisheni ezinye izifo, phakathi kwazo kukhona okusikhathazayo. Futhi kungukuthi kwisayensi yonke into ixhunyiwe. Sizokhuluma ngalezi zinkinga nezinye ngoSuku Lwe-Multiple Sclerosis.
Ubudlelwano phakathi komuthi wokugoma i-Covid-19 kanye ne-multiple sclerosis
NgoJanuwari walo nyaka, iphephabhuku iSayensi lashicilela umsebenzi owenziwa yiqembu elifanayo elahlanganisa umuthi wokugoma iPfizer / BioNTech wokulwa neCovid-19. Leli qembu lososayensi lihlolwe ngempumelelo omunye umuthi wokugoma we-messenger RNA (mRNA) ocindezela izimpawu ze-multiple sclerosis. Ukuhlolwa kwenziwe kuphela ezilwaneni nakumamodeli wazo amaningi e-sclerosis. Kumele siqaphele futhi yize sinezindaba ezinhle kakhulu futhi ezinethemba, iseyinde indlela okusamele sihambe ngayo.
Lolu cwaningo olwenziwe yiqembu lonjiniyela lomuthi wokugoma i-Pfizer / BioNTech olwa neCovid-19, lufika luthi (kubantu abavamile ngale ndaba) ukuthi ukuthuthukiswa kwezimpawu zesifo sokuqina kwemisipha kucindezelwe ngokuphelele, lapho isetshenziswa ngaphambi kokuba kuvele izimpawu. Ngakho-ke kungabhekwa njengokwelashwa kokuvikela.
Uma kufakwa lapho izilwane sezinezimpawu, zibuyela emuva kakhulu. Izilwane zibuyisa ingxenye noma konke ukubonga kwazo ngenxa yomphumela wokulwa nokuvuvukala, ongabuyiseli. Lezi yizindaba ezinethemba elikhulu impela, kepha ukwelashwa akukaze kufundwe ebantwini. Lesi yisivivinyo sokuqala.
Ukugonywa ngokumelene neziguli zeCovid-19 kanye ne-sclerosis
Iqembu le-Multiple Sclerosis Study leCatalan Neurology Society liqinisekise ukuthi imithi yokugoma egunyazwe iCovid-19 iphephile futhi aziyenzi ibe yimbi inkambo ye-multiple sclerosis. Ukugoma akuguquli indlela yokwenziwa kwezidakamizwa ezisetshenziselwa ukwelapha lesi sifo. Futhi akuboniswanga ukuthi kukhona ingozi eyengeziwe yokuqubuka ngemuva kokuthola umuthi wokugoma.
Ngakho-ke, kunokuqiniseka okunengqondo ukuthi Inganikezwa ezigulini eziningi ze-sclerosis, zombili lezo eziphathwayo kanye nezingezona. Kunabantu abangalashwa ngoba baqala ukugula kuphela, esigabeni saso sokuqala, abanezimpawu ezingezinhle. Okuwukuphela kwento egqamayo ukuthi ukusebenza komuthi ngokwawo kungancishiswa lapho usebenzisa izidakamizwa ezinamandla amakhulu wokuzivikela. Ngalo mqondo, bancoma ukuthi babheke isikhathi esihle sokugoma.
ICatalan Society of Neurology ivikela ukuthi kufanele ibhekwe njenge inani labantu elisengozini ezigulini ezine-multiple sclerosis ezindala kuneminyaka engama-65, ngokukhubazeka okuphezulu futhi ngubani okumele athole noma athole ukufakelwa umnkantsha wamathambo noma ama-immunosuppressants. Lokhu kuvezwa kufakiwe embhalweni: Izincomo zokugoma i-COVID-19 yeziguli ezine-MS.
Eminye Intuthuko Esifundweni Se-Multiple Sclerosis
Lobu budlelwano phakathi komuthi wokugoma i-RNA yesithunywa, ohlelo lwayo lungasetshenziswa nasezigulini ezine-multiple sclerosis, akuyona ukuphela kwento eyenzekayo ekwelashweni. Umsebenzi uyaqhubeka nokuthuthuka imishanguzo ebuyisela ama-oligodendrocyte alahlekile kanye ne-myelin.
Kuze kube manje kunezindlela zokwelashwa ezingaphezu kweziyishumi ezivunyelwe ze-multiple sclerosis kubantu. Lezi yimithi yokuvikela amandla omzimba, eyehlisa ijubane lesi sifo, kepha ayikwazi ukusinqanda ngokuphelele, noma iselaphe. Le mithi imvamisa iba nemiphumela emibi kakhulu, njengokunciphisa ukusebenza kokuzivikela kwamanye amagciwane, ngaphezu kwezindleko eziphezulu ezinhlelweni zezempilo.
Ngalo mqondo, ucwaningo olwenziwe e-United States luphethe ngokuthi Ukwelashwa kokuguqula izifo kuhlotshaniswa nezindleko eziphansi eziphelele, kokubili ngokuqondile nangokungaqondile kwezinhlelo zezempilo. Ama-69% alokhu kulondolozwa ahambelana nezindleko eziqondile zokunakekelwa kwezempilo kanti ama-31% asele kuya ekulahlekelweni komkhiqizo wabasebenzi.